Highlights

Share

Program Content

Activities

  • New Data in AD
    My Take on New Data in Atopic Dermatitis
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 30, 2021

    Expires: June 29, 2022

Activities

Dupilumab Facial Redness
Azoles for the Treatment of Patients Developing Dupilumab Facial Redness
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2021

Expires: June 09, 2022

Skin Pain in Children With AD
Analysis of Skin Pain in Children With Atopic Dermatitis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 11, 2021

Expires: June 10, 2022

JADE COMPARE Analysis
JADE COMPARE Analysis: Defining the Depth and Rapidity of Response of Abrocitinib and Dupilumab in Patients With Moderate to Severe Atopic Dermatitis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 15, 2021

Expires: June 14, 2022

Ruxolitinib Cream for AD
Rapid Decrease in Pruritus With Ruxolitinib Cream for Patients With Atopic Dermatitis: Pooled Results From TRuE-AD1 and TRuE-AD2
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 18, 2021

Expires: June 17, 2022

Faculty

cover img faculity

Robert Sidbury, MD, MPH

Professor, Department of Pediatrics
Chief, Division of Dermatology
Seattle Childrens Hospital
University of Washington School of Medicine
Seattle, Washington

Provided by

ProCE Banner

Supporters

Incyte Corporation